Triall Insights 🔍 According to an industry-wide survey, 87% of sponsors and CROs are using or planning to use decentralised clinical trials (DCTs) within the next 12 months. Despite growing adoption of DCT tools, fragmented technology is mentioned as a key issue that presents challenges related to site adoption, patient burden, and data collection & reporting. Source: veeva.com/resources/veeva-digital-clinical-trials-survey-report ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help us spread the news on Twitter: https://x.com/triallofficial/status/1711335240411537518?s=20 #blockchainforhealth #TRL

Triall Insights 🔍 According to an industry-wide survey, 87% of sponsors and CROs are using or planning to use decentralised clinical trials (DCTs) within the next 12 months. Despite growing adoption of DCT tools, fragmented technology is mentioned as a key issue that presents challenges related to site adoption, patient burden, and data collection & reporting. Source: veeva.com/resources/veeva-digital-clinical-trials-survey-report ⚡️ Trade $TRL at bit.ly/tradeTRL 🗣 Help us spread the news on Twitter: https://x.com/triallofficial/status/1711335240411537518?s=20 #blockchainforhealth #TRL

Fantastic news! Cronos expands IBC bridge to IRISnet 🤝 🌐 The latest IBC channel is now open, seamlessly bridging Cronos to IRISnet, providing you with a fast and efficient way to transfer assets between IRISnet and Cronos. Experience at https://cronos.org/bridge Follow 👀 Like👍 comment 💬 and stay tuned for more updates: https://twitter.com/irisnetwork/status/1711322863779696939